Mary Fisher joined SkinMedica as Chief Executive Officer, and a member of the Board of Directors, in April 2008. She was promoted to President & CEO in April of 2009. Ms. Fisher's previous experience includes more than 25 years in the pharmaceutical and biotechnology industries. Most recently, she was Chief Operating Officer of Acorda Therapeutics, a CNS company, with responsibility for corporate strategy and business development, financial planning, sales and marketing, and manufacturing. Previously, Ms. Fisher was VP, Strategic Healthcare and Commercial Operations for Cephalon, with responsibility for product planning and marketing, managed care sales, and manufacturing. Her earlier experience includes positions at Immunex and Boehringer Ingelheim. She is also a member of the Board of the Neuroscience Nursing Foundation.